In a major enforcement operation aimed at curbing the illegal distribution of pharmaceuticals, the Punjab state government has seized a stock of medicines valued at Rs 20 crore. Alongside these seizures, authorities have taken administrative action against the retail sector by suspending the licenses of 520 chemists found to be in violation of state regulations.

This crackdown is part of a broader effort by the state to address concerns regarding the misuse of medicinal products. While the specific nature of the violations leading to the license suspensions was not detailed in the initial reports, the scale of the action suggests a widespread audit of local pharmaceutical compliance.

Furthermore, the Punjab government has escalated the issue to the federal level. Officials have formally communicated with the Union Health Minister, expressing urgent concerns regarding the current lack of a comprehensive regulatory framework for e-pharmacies. The state argues that the rise of online medicine sales creates a loophole that complicates drug enforcement efforts. While the state is pushing for federal intervention to regulate these digital platforms, there is currently no indication of a timeline for when or how the Union government might respond to these specific requests for new oversight rules.